Four-factor prothrombin complex concentrate in trauma patients

被引：3
|
作者：
Bouzat, Pierre [1 ,4 ,5 ]
Hunt, Beverley J. J. [2 ]
Juffermans, Nicole P. P. [3 ]
机构：
[1] Univ Grenoble Alpes, Grenoble Inst Neurosci, CHU Grenoble Alpes, Inserm, F-38000 Grenoble, France
[2] Guys & St ThomasNHS Fdn Trust, Ctr Thrombosis & Haemophilia, Westminster Bridge Rd, London SE1 7EH, England
[3] Erasmus MC, Dept Intens Care, Lab Translat Intens Care, Rotterdam, Netherlands
[4] Hop Albert Michallon, Pole Anesthesie Reanimat, BP 217, F-38043 Grenoble, France
[5] Univ Grenoble Alpes, Grenoble Inst Neurosci, CHU Grenoble Alpes, Inserm, F-38000 Grenoble, France
来源：
INTENSIVE CARE MEDICINE | 2023年 / 49卷 / 10期
关键词：
FRESH-FROZEN PLASMA; COAGULOPATHY; REVERSAL;
D O I：
10.1007/s00134-023-07170-0
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1242 / 1244
页数：3
相关论文
共 50 条
  • [31] Four-factor prothrombin complex concentrate administration after expanding intracranial hemorrhage status post administration of andexanet alfa
    Blackburn, Matthew
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 62 : 144.e1 - 144.e3
  • [32] Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage
    Cicci, Corey D.
    Weiss, Ashley
    Dang, Cathyyen
    Stanton, Matthew
    Feldman, Ryan
    PHARMACOTHERAPY, 2022, 42 (05): : 366 - 374
  • [33] Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series
    Liu, JiTong
    Elsamadisi, Pansy
    Philips, Eli
    Bauer, Kenneth A.
    Eche, Ifeoma M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (16) : 1323 - 1329
  • [34] Fixed vs Weight-Based Dosing of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Patients With a Non-Neurologic Hemorrhage
    Stokes, Tyson
    Johnson, Christopher
    Fish, Tyler
    Mishler, Aimee
    JOURNAL OF PHARMACY PRACTICE, 2025,
  • [35] Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study
    Brian D. Adkins
    Hila Shaim
    Abdul Abid
    Adam Gonzalez
    Abe DeAnda
    Sean G. Yates
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 74 - 82
  • [36] Multi-centered evaluation of a novel fixed-dose four-factor prothrombin complex concentrate protocol for warfarin reversal
    Dietrich, Scott K.
    Mixon, Mark
    Holowatyj, Michael
    Werth, Josh C.
    Delgado, Stephanie A.
    Mascolo, Nicole E.
    Meister, Erin R.
    Zoucha, Shane M.
    Trujillo, Toby C.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (10) : 2096 - 2100
  • [37] Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal
    Zemrak, Wesley
    Manuel, Francis
    Smith, Kathryn E.
    Rolfe, Stephen
    Hayes, Timothy
    Trowbridge, Robert L.
    Carlone, Brian
    Seder, David
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (02) : 263 - 271
  • [38] Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal
    Wesley Zemrak
    Francis Manuel
    Kathryn E. Smith
    Stephen Rolfe
    Timothy Hayes
    Robert L. Trowbridge
    Brian Carlone
    David Seder
    Journal of Thrombosis and Thrombolysis, 2019, 47 : 263 - 271
  • [39] Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration
    Nowak, Thomas
    Popp, Birgit
    Groener, Albrecht
    Schaefer, Wolfram
    Kalina, Uwe
    Enssle, Karlheinz
    Roth, Nathan J.
    TRANSFUSION, 2017, 57 (05) : 1184 - 1191
  • [40] Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?
    Makris, Mike
    van Veen, Joost J.
    BLOOD TRANSFUSION, 2011, 9 (02) : 117 - 119
12345